19-21536517-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001001415.4(ZNF429):āc.464A>Gā(p.Tyr155Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000267 in 1,612,662 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001001415.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF429 | ENST00000358491.9 | c.464A>G | p.Tyr155Cys | missense_variant | 4/4 | 3 | NM_001001415.4 | ENSP00000351280.3 | ||
ZNF429 | ENST00000597078.5 | c.227-5247A>G | intron_variant | 1 | ENSP00000470300.1 | |||||
ZNF429 | ENST00000594022.1 | n.*18A>G | downstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152252Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000241 AC: 6AN: 248638Hom.: 0 AF XY: 0.00000741 AC XY: 1AN XY: 134944
GnomAD4 exome AF: 0.0000267 AC: 39AN: 1460410Hom.: 0 Cov.: 31 AF XY: 0.0000262 AC XY: 19AN XY: 726550
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152252Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74392
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 15, 2024 | The c.464A>G (p.Y155C) alteration is located in exon 4 (coding exon 4) of the ZNF429 gene. This alteration results from a A to G substitution at nucleotide position 464, causing the tyrosine (Y) at amino acid position 155 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at